GL1X · GenesisL1 explorer

MolNFT v1 · #88489 · protein

Crystal structure of human gamma-BUTYROBETAINE,2-oxoglutarate in complex with 449, a novel substrate

4CWD · Gamma-butyrobetaine dioxygenase: “Crystal structure of human gamma-BUTYROBETAINE,2-oxoglutarate in complex with 449, a novel substrate”. X-ray diffraction, 4 ligands (449, OGA, NI), 2 pockets (best druggability 0.77). MolNFT v1…

PDB
4CWD
Type
protein
Length
385 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Gamma-butyrobetaine dioxygenase
EC
1.14.11.1
UniProt
O75936
Ligands
449, OGA, NI, ZN
Pockets
2 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGamma-butyrobetaine dioxygenase (EC 1.14.11.1)protein38530% helix, 29% strandO75936

Ligands and binding sites

  • 449 · 4-carboxy-1,1-dimethylpiperidin-1-ium · ligand · chains A
  • OGA · N-oxalylglycine · ligand · chains A
  • NI · Nickel (II) ion · metal · chains A
  • ZN · Zinc ion · metal · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11660.770.9336449, OGA
21390.440.7519empty

Compared structures

  • 4CWD · Crystal structure of human gamma-BUTYROBETAINE,2-oxoglutarate in complex with 449, a… · the same entry in another collection · chain A against A, TM-score 1.00
  • O75936 · AlphaFold monomer V2.0 prediction for gamma-butyrobetaine dioxygenase (O75936) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.